In a lawsuit filed on June 25, 2013, the Securities and Exchange Commission says that Dean Norman Janes, CEO of Imaging3, intentionally kept investors in the dark about the true reasons why the FDA turned down his company's application to market its Dominion Volumetric Imaging Scanner